Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Expert Guidance from the ACR/ARP Access in Rheumatology Meeting

Glen Rodman  |  July 12, 2023

Additionally, he recommended delegating tasks to nurse practitioners within the parameters of what is legal in each state, and insuring drugs in case of a power outage or other emergency. Dr. Phillips emphasized the necessity of being prepared for contingencies and never infusing without a clinician on site.

As with the two preceding speakers, Dr. Phillips recommended keeping a close watch on drug prices, to buy in bulk when prices are low and not to hesitate to negotiate or switch vendors.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Optimize Patient Access to Treatment

Colin Edgerton, MD, RhMSUS, opened the second session with a presentation about biosimilars. Dr. Edgerton is a founding member of Articularis Healthcare, one of the largest rheumatology practices in the U.S., spanning the states of South Carolina and Georgia. Biosimilars can be a great option for patients and can make treatment more financially accessible, he said. In his experience, patients adhere to their medication regimens equally, regardless of whether the drug is the originator or a biosimilar, and the efficacy of the drug itself is not reduced.

Dr. Edgerton identified some challenges related to the use of biosimilars, such as complications with prior authorization and clinical concern regarding multiple prescription switches.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We don’t want a patient getting changed to another adalimumab every quarter or two,” said Dr. Edgerton. Multiple switches in medications may even cause a nocebo effect for patients, who may be understandably confused or anxious about having to adjust to a new drug.

Nicholas Turkas, MS, is the senior director of patient education and community connections for the Arthritis Foundation. Mr. Turkas’s presentation explored the pros and cons of original Medicare vs. Medicare Advantage plans. Original Medicare is a fee-for-service program, which means there is a set, non-negotiable price for any given procedure. Medicare Advantage, however, is managed care, which requires patients to use a limited network of providers and has stricter rules around prior authorization. When patients near age 65, Mr. Turkas recommends having a discussion with them about switching to Medicare, which has “huge implications in terms of access to care.”

Patients may be drawn to Medicare Advantage plans because of the lower up-front cost and such benefits as gym memberships. Medicare Advantage plans may also offer coverage for some care that original Medicare does not, such as vision, dental or hearing. However, the limitations of Medicare Advantage may make care much more expensive for patients switching from original Medicare, and because plan coverage specifics change from year to year, patients may not always be able to see the same doctor.

Page: 1 2 3 | Single Page
Share: 

Filed under:Meeting ReportsPractice Management Tagged with:Access to careACR Education Exchange 2023financespatient carePractice ManagementTreatment

Related Articles

    Marching to the Biosimilar Beat: Questions on Rollout Remain

    September 7, 2023

    The availability of biosimilars for the treatment of patients with rheumatic diseases exploded in 2023. Here’s where we stand and what to expect going forward.

    Georgia Bonney

    Prior Authorization Woes: Barriers to & Delays in Care, Administrative Hassles & Potential Solutions

    August 6, 2021

    As insurers phase out pandemic-related flexibilities, many are raising new obstacles to try to limit their financial exposure.

    Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?

    October 17, 2017

    As questions about biosimilar medications swirl among U.S. rheumatologists, a recently released report sheds some light on the European experience with biosimilars—and may offer some important insights for the U.S. market. The report, Biosimilars in the EU: Information Guide for Healthcare Professionals, was released in late April by the European Medicines Agency (EMA) and the…

    Prior Authorization Is Under Review

    February 10, 2022

    I just couldn’t believe it. Like all of you, I receive many requests to see patients urgently. And like all of you, I can’t possibly accommodate all of those requests. So I triage: I look through the referrals and try to differentiate patients who want to be seen from those who need to be seen….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences